Have serious kidney or liver problems
A live consultation is available on request, and a six-month check-in is required to keep your file current
Five of these trials have shown superiority in reducing MACE compared to placebo, while all have confirmed the cardiovascular safety of GLP-1 RAs ( 4.3.1 Cardiovascular outcomes in GLP-1 RAs studies The ELIXA trial, which included 6068 patients, was the first to investigate the cardiovascular effects of GLP-1 RAs
If tirzepatide isnt the right fit, we discuss alternatives within our health and wellness offerings, including our medically supervised tirzepatide program when appropriate
However, most regain weight after stopping, so longer treatment typically produces more durable results
Discount per Quantity Orders over $200 receive: FREE - USPS priority shipping BPC-157, TB-500 & GHK-Cu Peptide Blend The GHK-Cu, TB 500, and BPC 157 peptide blend, is a composite research formulation studied for its relevance to cellular repair signaling, angiogenic modulation, and extracellular matrix regulation